Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-15-010524
Filing Date
2015-06-30
Accepted
2015-06-30 18:09:28
Documents
1
Period of Report
2015-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3992
  Complete submission text file 0001179110-15-010524.txt   5557
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

EIN.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYMABAY THERAPEUTICS, INC. 7999 GATEWAY BLVD., SUITE 130 NEWARK CA 94560
Business Address
Rosemark Kirk (Reporting) CIK: 0001640908 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36500 | Film No.: 15962588